EMEA-003533-PIP01-23
Submitted by Anonymous (not verified) on 11 March 2026 - 12:43
EMEA-003533-PIP01-23
EMEA-003532-PIP01-23
Submitted by Anonymous (not verified) on 11 March 2026 - 12:39
EMEA-003532-PIP01-23
EMEA-002476-PIP03-24
Submitted by Anonymous (not verified) on 11 March 2026 - 12:35
EMEA-002476-PIP03-24
Human medicines European public assessment report (EPAR): Kirsty (previously Kixelle), insulin aspart, Date of authorisation: 05/02/2021, Revision: 6, Status: Authorised
Submitted by Anonymous (not verified) on 11 March 2026 - 10:46
Human medicines European public assessment report (EPAR): Kirsty (previously Kixelle), insulin aspart, Date of authorisation: 05/02/2021, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Lysodren, mitotane, Date of authorisation: 28/04/2004, Revision: 24, Status: Authorised
Submitted by Anonymous (not verified) on 11 March 2026 - 9:53
Human medicines European public assessment report (EPAR): Lysodren, mitotane, Date of authorisation: 28/04/2004, Revision: 24, Status: Authorised
Vaxchora: avoiding errors when making up and using the vaccine
Submitted by Anonymous (not verified) on 11 March 2026 - 9:01
Vaxchora: avoiding errors when making up and using the vaccine
EMA/PE/0000223608
Submitted by Anonymous (not verified) on 11 March 2026 - 8:00
EMA/PE/0000223608
EMA/PE/0000223656
Submitted by Anonymous (not verified) on 11 March 2026 - 8:00
EMA/PE/0000223656
EMA/PE/0000223523
Submitted by Anonymous (not verified) on 10 March 2026 - 16:18
EMA/PE/0000223523
EMA/PE/0000223677
Submitted by Anonymous (not verified) on 10 March 2026 - 16:18
EMA/PE/0000223677